Park Medi World Limited share price
Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology, critical care, chest and respiratory diseases, dental care, dermatology, endocrinology, paediatrics, internal medicine and geriatrics, rheumatology, ENT, ophthalmology, obstetrics and gynaecology, interventional radiology and imaging, psychi…Read more
- Market Cap₹ 10,181 Cr.
- Current Price₹ 235.70
- High / Low₹ 305 / 138
- Stock P/E35.9
- Book Value₹ 51
- Dividend Yield0.00 %
- ROCE17.9 %
- ROE16.80 %
- Face Value₹ 2.0
More figures (10)
- EPS (TTM)₹ 6.57
- Price / Book4.64
- OPM23.3 %
- Debt / Equity0.18
- Sales growth (3Y)9.6 %
- Profit growth (3Y)5.5 %
- Promoter holding83.9 %
- EV / EBITDA20.5
- Beta—
- All-time high₹ 305
Price chart
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| PARKHOSPS | -14.73% | -18.89% | +14.52% | +60.83% | — | — | — |
| Nifty 50 | -0.31% | -3.85% | -4.34% | -11.42% | -9.53% | +5.46% | +4.76% |
Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.
Quick take
- Park Medi World Limited is in the Medical Care Facilities industry (Healthcare), with a market value of ₹10,181 crore.
- It trades at 35.9 times its last 12 months' earnings and 4.6 times book value.
- Revenue grew 9.6% a year over the last 3 years, profit 5.5% a year.
- Return on equity was 16.8% and return on capital employed 17.9% in the latest year.
- Debt was 0.18 times shareholders' equity.
- The share price is 22.7% below its 52-week high.
- Promoters and insiders hold about 83.9%; institutions about 5.7%.
Pros
AI- Strong return on equity: 19.1% on average over the last 3 years.
- Borrowings are moderate at 0.18 times shareholders' equity.
Cons
AI- The company has not paid a dividend recently.
Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.
AI analysis
Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.
About Park Medi World Limited
Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology, critical care, chest and respiratory diseases, dental care, dermatology, endocrinology, paediatrics, internal medicine and geriatrics, rheumatology, ENT, ophthalmology, obstetrics and gynaecology, interventional radiology and imaging, psychiatry, pathology and microbiology, paediatric surgery, fertility management, nuclear medicine services. It operates NABH accredited multi-super specialty hospitals under the Park brand name. Park Medi …
- Employees
- 6,423
- Head office
- Gurugram
- NSE industry
- Healthcare
Peer comparison
HealthcareHealthcareMedical Care Facilities
Part ofNifty Microcap 250
| S.No. | Company | CMP ₹ | P/E | Mar Cap ₹ Cr | Div Yld % | NP Qtr ₹ Cr | Qtr Profit Var % | Sales Qtr ₹ Cr | Qtr Sales Var % | ROCE % | ROE % | P/B | OPM % | Debt / Eq | Prom. Hold. % | Sales ₹ Cr | Sales Var 3Yrs % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Park Medi World | 235.70 | 35.9 | 10,181 | 0.00 | 89 | — | 476 | — | 17.9 | 16.8 | 4.64 | 23.3 | 0.18 | 83.94 | 1,679 | 9.6 |
| 2. | Apollo Hospitals Enterprise | 7,890.00 | 54.3 | 1,13,446 | 0.25 | 610 | 38.41 | 7,044 | 20.56 | 19.2 | 21.9 | 11.97 | 11.7 | 0.90 | 28.39 | 25,229 | 14.8 |
| 3. | Max Healthcare Institute | 846.00 | 56.7 | 82,342 | 0.23 | 323 | 4.87 | 2,366 | 16.70 | 12.6 | 14.3 | 7.66 | 22.8 | 0.32 | 28.20 | 8,225 | 22.4 |
| 4. | Aster DM Quality Care | 674.35 | 109.3 | 58,781 | 0.44 | 29 | -68.70 | 1,311 | 21.60 | 9.4 | 9.7 | 7.59 | 14.2 | 0.49 | 64.26 | 4,643 | 15.7 |
| 5. | Fortis Healthcare | 736.50 | 53.1 | 55,603 | 0.13 | 266 | 2.35 | 2,545 | 17.46 | 11.9 | 11.1 | 5.62 | 17.8 | 0.35 | 35.19 | 9,048 | 13.3 |
| 6. | Narayana Hrudayalaya | 1,719.40 | 42.5 | 34,921 | 0.26 | 207 | 5.37 | 2,684 | 78.05 | 11.4 | 19.7 | 7.70 | 15.5 | 1.29 | 67.23 | 7,896 | 20.5 |
| 7. | Global Health | 1,240.00 | 60.0 | 33,322 | 0.04 | 159 | -0.18 | 1,304 | 26.50 | 15.0 | 15.1 | 8.41 | 16.8 | 0.30 | 66.39 | 4,318 | 17.2 |
| 8. | Krishna Institute of Medical Sciences | 685.60 | 134.4 | 28,796 | 0.00 | 42 | -47.20 | 1,180 | 35.33 | 8.1 | 11.0 | 12.21 | 13.8 | 1.89 | 41.74 | 3,872 | 21.3 |
| 9. | Rainbow Children's Medicare | 1,248.90 | 44.4 | 12,634 | 0.28 | 63 | 16.23 | 470 | 33.17 | 16.8 | 17.9 | 7.69 | 23.7 | 0.54 | 52.29 | 1,703 | 13.1 |
| 10. | HealthCare Global Enterprises | 588.20 | 379.5 | 8,782 | 0.00 | 14 | 189.89 | 693 | 13.34 | 6.7 | 1.2 | 6.39 | 8.8 | 1.30 | 70.64 | 2,522 | 14.6 |
| Median: 16 Co. | 791.25 | 53.1 | 11,407 | 0.09 | 124 | 4.87 | 1,307 | 21.60 | 12.3 | 15.7 | 7.63 | 16.2 | 0.52 | 58.28 | 4,481 | 16.5 |
Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.
Quarterly Results
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.
Profit & Loss
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Projection — your assumptions
Starts from the last four reported quarters (TTM) and applies the figures you enter; growth is pre-filled with the company's own past sales growth. This is a what-if calculator for illustration, not a forecast, estimate or recommendation.
Related party transactions
Related-party transactions are dealings with promoters, directors, subsidiaries and associates. Companies disclose them to the exchanges every half-year and in detail in the notes to their annual report.
No separate related-party filing among the recent announcements of the company.
Full details: notes to the Financial Year 2026 annual report (related party disclosures).
| ₹ Cr | Mar 2026 |
|---|---|
| Sales | 1,679 |
| 1,235 | |
| Material Cost % | 18% |
| Employee Cost % | 19% |
| Other Expenses % | 37% |
| Operating Profit | 444 |
| OPM % | 26% |
| Other Income | 32 |
| Interest | 59 |
| Depreciation | 62 |
| Profit before tax | 355 |
| 23% | |
| Current tax | 82 |
| Deferred tax | -1 |
| 274 | |
| Minority share | 15 |
| Profit to shareholders | 258 |
| EPS in Rs | 6.87 |
Return on Equity
- 4 Years:
- 22%
- Last Year:
- 17%
| ₹ Cr | Mar 2026 |
|---|---|
| Sales | 129 |
| 77 | |
| Material Cost % | 12% |
| Employee Cost % | 15% |
| Other Expenses % | 33% |
| Operating Profit | 52 |
| OPM % | 41% |
| Other Income | 10 |
| Interest | 13 |
| Depreciation | 5 |
| Profit before tax | 45 |
| 19% | |
| Current tax | 11 |
| Deferred tax | -2 |
| Net Profit | 37 |
| EPS in Rs | 0.92 |
Return on Equity
- 4 Years:
- 22%
- Last Year:
- 17%
Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.
Balance Sheet
Consolidated figures in ₹ crore, as at 31 March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 77 | 77 | 77 | 86 |
| Reserves | 610 | 806 | 975 | 1,936 |
| 576 | 687 | 682 | 364 | |
| Long term borrowings | 319 | 391 | 384 | 19 |
| Short term borrowings | 238 | 242 | 238 | 209 |
| 331 | 343 | 405 | 427 | |
| Trade payables | 60 | 90 | 136 | 109 |
| Minority interest | 43 | 53 | 67 | 82 |
| Current liabilities | 521 | 527 | 557 | 529 |
| Total Liabilities | 1,593 | 1,912 | 2,139 | 2,813 |
| 481 | 793 | 819 | 1,050 | |
| Gross block | 550 | 958 | 977 | 1,280 |
| Accumulated depreciation | 70 | 165 | 158 | 230 |
| Goodwill & intangibles | 77 | 78 | 119 | 391 |
| CWIP | 22 | 34 | 48 | 132 |
| 1,090 | 1,085 | 1,272 | 1,632 | |
| Inventories | 2 | 2 | 3 | 3 |
| Trade receivables | 576 | 511 | 614 | 593 |
| Cash & equivalents | 100 | 77 | 103 | 237 |
| Current assets | 819 | 943 | 1,034 | 1,088 |
| Total Assets | 1,593 | 1,912 | 2,139 | 2,813 |
Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.
Cash Flows
Consolidated figures in ₹ crore, financial years ending March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 195 | 361 | 215 | 329 | |
| Profit for the year | 220 | 153 | 202 | 258 |
| Working capital changes | -121 | 105 | -80 | -17 |
| Direct taxes paid | -100 | -100 | -84 | -98 |
| -180 | -255 | -100 | -333 | |
| Fixed assets purchased | -98 | -71 | -145 | -120 |
| Fixed assets sold | 5 | 4 | 34 | |
| 2 | -130 | -89 | 121 | |
| Proceeds from borrowings | 116 | 271 | 39 | |
| Repayment of borrowings | -142 | -199 | -55 | |
| Interest paid | -49 | -67 | -55 | -55 |
| Net Cash Flow | 17 | -23 | 26 | 116 |
| Free Cash Flow | 97 | 290 | 70 | 209 |
Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.
Ratios
| Ratio | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| ROE | 32.0% | 19.6% | 20.8% | 16.8% |
| ROCE | 34.0% | 20.8% | 21.8% | 17.9% |
| Operating margin | 29.7% | 21.9% | 22.8% | 23.3% |
| Net margin | 17.5% | 12.5% | 14.5% | 15.6% |
| Debt / equity | 0.84 | 0.78 | 0.65 | 0.18 |
| Current ratio | 1.57 | 1.79 | 1.86 | 2.06 |
| Debtor days | 168 | 152 | 161 | 131 |
| Inventory days | 1 | 2 | 2 | 2 |
| Days payable | 53 | 70 | 89 | 64 |
| Cash conversion cycle | 116 | 84 | 74 | 69 |
| Working capital days | 87 | 124 | 125 | 124 |
Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.
Shareholding Pattern
Numbers in percentages · as filed with NSE each quarter
- Promoters 82.89%
- FIIs 0.82%
- DIIs 8.95%
- Public 7.33%
| % | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Promoters | 82.89% | 82.89% | 82.89% |
| 1.28% | 0.86% | 0.82% | |
| Foreign portfolio investors (Cat. I) | 1.28% | 0.78% | 0.64% |
| Foreign portfolio investors (Cat. II) | 0.08% | 0.18% | |
| 8.78% | 9.25% | 8.95% | |
| Mutual funds | 5.17% | 5.62% | 5.66% |
| Insurance companies | 1.06% | 0.86% | 0.68% |
| Alternative investment funds | 2.35% | 2.47% | 2.38% |
| 7.05% | 6.99% | 7.33% | |
| Retail (up to ₹2 lakh) | 3.88% | 2.47% | 2.86% |
| HNIs (above ₹2 lakh) | 1.13% | 1.48% | 1.68% |
| NRIs | 0.02% | 0.06% | 0.05% |
| Bodies corporate | 1.63% | 2.65% | 2.43% |
| No. of Shareholders | 1,14,600 | 50,863 | 52,428 |
Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.
Mutual funds & institutions holding Park Medi World
| Holder (above 1%) | Stake |
|---|---|
| Kotak Contra FundMutual fund | 5.11% |
| Carnelian Bharat Amritkaal FundAIF | 1.04% |
As named in the shareholding pattern for Jun 2026 filed with NSE; mutual funds together hold 5.66% of the company. Shareholders below 1% are not named in the filing.
Documents
Announcements
- UpdatesPark Medi World Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015'.14-Oct-2026
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Park Medi World Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended September 30, 202608-Oct-2026
- Trading WindowPark Medi World Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201528-Sep-2026
- Shareholders meetingPark Medi World Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2026. Further, the company has informed the Exchange r…22-Sep-2026
- Shareholders meetingPark Medi World Limited has informed the Exchange regarding Proceedings of 15th Annual General Meeting held on September 22, 202622-Sep-2026
- Press ReleasePark Medi World Limited has informed the Exchange regarding a press release dated September 22, 2026, titled "Park Group of Hospitals Wins Three Honours at Healthcare Pioneers of …22-Sep-2026
- Arrangements for strategic, technical, manufacturing, or marketing tie upPark Medi World Limited has informed the Exchange about Operations and Management Agreement with Axis Educational Society16-Sep-2026
- AcquisitionPark Medi World Limited has informed the Exchange about incorporation of a Wholly owned subsidiary08-Sep-2026
- UpdatesPark Medi World Limited has informed the Exchange regarding 'Re-filing of Financial Results for the Quarter Ended June 30, 2026 in Machine Readable/Searchable Format'.08-Sep-2026
- Shareholders meetingPark Medi World Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot notice dated August 03, 202604-Sep-2026
- AcquisitionPark Medi World Limited has informed the Exchange about Incorporation of Wholly Owned Subsidiary31-Aug-2026
- Outcome of Board MeetingPark Medi World Limited has informed the Exchange regarding Outcome of Board Meeting held on August 31, 2026.31-Aug-2026
Concalls & investor meets
- Analysts/Institutional Investor Meet/Con. Call UpdatesPark Medi World Limited has informed the Exchange about Cancellation of Schedule of meet16-Sep-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesPark Medi World Limited has informed the Exchange about Meeting with Analysts/Investors05-Sep-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesPark Medi World Limited has informed the Exchange about Schedule of meet18-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesPark Medi World Limited has informed the Exchange about Transcript08-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesPark Medi World Limited has informed the Exchange about Schedule of meet05-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesPark Medi World Limited has informed the Exchange about Link of Recording04-Aug-2026
- Investor PresentationPark Medi World Limited has informed the Exchange about Investor Presentation03-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesPark Medi World Limited has informed the Exchange about Schedule of meet29-Jul-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesPark Medi World Limited has informed the Exchange about Schedule of meet03-Jul-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesPark Medi World Limited has informed the Exchange about Schedule of meet08-Jun-2026
Filings made by the company with NSE; documents open on NSE's website.
Key dates
- Ex-dividend date
- 1 Jan 1970
- Latest quarter
- 30 Jun 2026
- Financial year end
- 31 Mar 2026
Trade with our broking desk
Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.
Latest news
In the news
- Park Medi World PARKHOSPS Income Tax Verification DisclosureKalkine India · 2 d ago
- Park (PARKHOSPS.NS) Stock: Slides -1.92% — Support Test Looms at ₹254.17 2026-10-07 - SuperTrend Fliphttps://www.siam.in/ · 8 Oct 2026
- Park Medi World PARKHOSPS Trading Window Closure Q2 FY27Kalkine India · 28 Sep 2026
From the company (NSE)
- UpdatesPark Medi World Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015'.NSE filing · 14-Oct-2026
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Park Medi World Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended September 30, 2026NSE filing · 08-Oct-2026
- Trading WindowPark Medi World Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015NSE filing · 28-Sep-2026
- Shareholders meetingPark Medi World Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2026. Further, the company has informed the Exchange r…NSE filing · 22-Sep-2026
- Shareholders meetingPark Medi World Limited has informed the Exchange regarding Proceedings of 15th Annual General Meeting held on September 22, 2026NSE filing · 22-Sep-2026
- Press ReleasePark Medi World Limited has informed the Exchange regarding a press release dated September 22, 2026, titled "Park Group of Hospitals Wins Three Honours at Healthcare Pioneers of …NSE filing · 22-Sep-2026
- Arrangements for strategic, technical, manufacturing, or marketing tie upPark Medi World Limited has informed the Exchange about Operations and Management Agreement with Axis Educational SocietyNSE filing · 16-Sep-2026
- AcquisitionPark Medi World Limited has informed the Exchange about incorporation of a Wholly owned subsidiaryNSE filing · 08-Sep-2026
Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.
Questions about Park Medi World Limited
What is the share price of Park Medi World Limited today?
What is the market cap of Park Medi World Limited?
What is the P/E ratio of Park Medi World Limited?
Is Park Medi World Limited a good investment?
How can I buy Park Medi World Limited shares?
Have a question about this topic?
Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.
Book your free wealth consultation
- 100% free
- No obligation
- Reply within 2 hours
Request received!
Thank you for trusting Plenitude Connect. An expert will contact you shortly. Please check your inbox for details.